Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Department of Mental Health Law & Policy, University of South Florida, Tampa, FL, USA.
Ann Med. 2022 Dec;54(1):1714-1724. doi: 10.1080/07853890.2022.2084154. Epub 2022 Jul 1.
The syndemic between opioid use disorder (OUD), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) results in excessive burdens on the healthcare system. Integrating these siloed systems of care is critical to address all three conditions adequately. In this implementation project, we assessed the data capacity of the health system to measure a cascade of care (COC) across HIV, HCV and OUD services in five states to help guide public health planning.
Data for this study were gathered from publicly available datasets and reports from government (SAMSHA, CMS, HRSA and CDC) sites. We created, where possible, COCs for HIV, HCV, and OUD spanning population estimate, diagnosis, treatment initiation, treatment retention, and patient outcomes for each of five states in the study.
The process of data collection showed that baseline COCs examining the intersections of OUD, HIV, and HCV cannot be produced and that there are missing data in all states examined. Collection of specific data points is not consistent across all states. States are better at reporting HIV cascades due to federal requirements. Only gross estimates could be made for OUD cascades in all states because data are separated by payer source, leaving no central point of data collection from all sources. Data for HCV were not publicly available.
It is difficult to assess the strategies needed or the progress made towards increasing treatment access and decreasing the burden of disease without the ability to construct an accurate baseline. Using integrated COCs with relevant benchmarks can not only guide public health planning, but also provide meaningful targets for intervention.KEY MESSAGESWhile HIV COCs are available for most states at least annually, they are not disaggregated for populations with co-occurring OUD or HCV.Data to calculate HCV COC are not available and data to calculate OUD COC are partially available, but only for specific payers.States do not have systems in place to measure the scope of the syndemic or to identify targets for quality improvement activities.
阿片类药物使用障碍(OUD)、丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)的综合征会给医疗保健系统带来巨大负担。整合这些孤立的护理系统对于充分解决这三种疾病至关重要。在这个实施项目中,我们评估了卫生系统衡量 HIV、HCV 和 OUD 服务中护理级联(COC)的能力,以帮助指导公共卫生规划。
本研究的数据来自政府(SAMSHA、CMS、HRSA 和 CDC)网站上公开的数据集和报告。我们尽可能地为五个州的 HIV、HCV 和 OUD 创建了 COC,涵盖了每个州的人口估计、诊断、治疗开始、治疗保留和患者结局。
数据收集过程表明,无法生成检查 OUD、HIV 和 HCV 交叉点的基线 COC,并且在所检查的所有州都存在数据缺失。在所有检查的州,特定数据点的收集都不一致。由于联邦要求,各州更擅长报告 HIV 级联。由于数据按付款来源分开,没有从所有来源收集数据的中心点,因此所有州的 OUD 级联只能进行大致估计。HCV 数据不可用。
如果没有构建准确的基线,就很难评估增加治疗机会和减少疾病负担所需的策略或取得的进展。使用具有相关基准的综合 COC 不仅可以指导公共卫生规划,还可以为干预提供有意义的目标。
虽然大多数州至少每年都可以获得 HIV COC,但它们没有针对同时患有 OUD 或 HCV 的人群进行细分。没有用于计算 HCV COC 的数据,并且仅为特定付款人提供了用于计算 OUD COC 的部分数据。各州没有系统来衡量综合征的范围或确定质量改进活动的目标。